“It is one of the most challenging cancers to treat, with five-year survival rates ranging from approximately 5% to 30%,” noted report co-author Dr. Jian Zhou of Fudan University in China. “We risk seeing close to a doubling of cases and deaths from liver cancer over the next quarter of a century without urgent action to reverse this trend.”

At least 60% of liver cancers globally are preventable through risk-factor reduction, including obesity-linked metabolic dysfunction-associated steatotic liver disease.

A recent study reveals that reducing obesity, alcohol consumption, and increasing hepatitis vaccination could prevent most global liver cancer cases.